Literature DB >> 15721802

The enhancing effects of hippocampal infusions of glucose are not restricted to spatial working memory.

Desiree L Krebs1, Marise B Parent.   

Abstract

Extensive evidence shows that hippocampal infusions of glucose enhance spontaneous alternation (SA) performance or reverse deficits in this task. The current experiments determined whether the enhancing effects of hippocampal infusions of glucose are restricted to spatial working memory. Specifically we tested whether hippocampal infusions of glucose would reverse deficits in an emotional reference memory task (continuous multiple trial inhibitory avoidance [CMIA]) produced by septal infusions of the gamma-aminobutyric acid agonist muscimol. Male Sprague-Dawley rats were given septal infusions of vehicle or muscimol (0.15 nmol: SA; 5 nmol: CMIA) combined with hippocampal infusions of vehicle or glucose (50 nmol) 15 min prior to assessing SA or CMIA training. CMIA retention was tested 48 h later. Muscimol infusions decreased percent alternation scores and avoidance retention latencies. Importantly, hippocampal infusions of glucose reversed the deficits produced by the septal muscimol infusions on both tasks. These findings show for the first time that hippocampal glucose infusions also influence emotional memory, indicating that the enhancing effects of glucose generalize to memory tasks that vary in motivational and cognitive demand.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721802     DOI: 10.1016/j.nlm.2004.10.004

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  10 in total

1.  Hippocampal infusions of pyruvate reverse the memory-impairing effects of septal muscimol infusions.

Authors:  Desiree L Krebs; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2005-09-27       Impact factor: 4.432

Review 2.  Regulation of memory - from the adrenal medulla to liver to astrocytes to neurons.

Authors:  Paul E Gold
Journal:  Brain Res Bull       Date:  2014-01-07       Impact factor: 4.077

3.  Glucose attenuates impairments in memory and CREB activation produced by an α4β2 but not an α7 nicotinic receptor antagonist.

Authors:  Ken A Morris; Sisi Li; Duat D Bui; Paul E Gold
Journal:  Neuropharmacology       Date:  2012-11-16       Impact factor: 5.250

4.  Septal co-infusions of glucose with the benzodiazepine agonist chlordiazepoxide impair memory, but co-infusions of glucose with the opiate morphine do not.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Physiol Behav       Date:  2009-12-22

5.  Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats.

Authors:  Sherin Antony; T Peeyush Kumar; Jobin Mathew; T R Anju; C S Paulose
Journal:  J Biomed Sci       Date:  2010-02-05       Impact factor: 8.410

6.  Hippocampal infusions of glucose reverse memory deficits produced by co-infusions of a GABA receptor agonist.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Neurobiol Learn Mem       Date:  2007-08-28       Impact factor: 2.877

7.  Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels.

Authors:  Desiree L Krebs-Kraft; Gail Rauw; Glen B Baker; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

8.  The memory-impairing effects of septal GABA receptor activation involve GABAergic septo-hippocampal projection neurons.

Authors:  Desiree L Krebs-Kraft; Marina G Wheeler; Marise B Parent
Journal:  Learn Mem       Date:  2007-12-17       Impact factor: 2.460

9.  Center for Behavioral Neuroscience: a prototype multi-institutional collaborative research center.

Authors:  Kelly R Powell; H Elliott Albers
Journal:  J Biomed Discov Collab       Date:  2006-07-17

Review 10.  The neuroenergetics of stress hormones in the hippocampus and implications for memory.

Authors:  Danielle M Osborne; Jiah Pearson-Leary; Ewan C McNay
Journal:  Front Neurosci       Date:  2015-05-06       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.